Karen Mendelson

Karen Mendelson has over 20 years of work experience in the field of scientific research. Karen is currently working at Sapience Therapeutics, Inc. as a Senior Scientist. Prior to this, they worked at Mount Sinai Health System for five years as a Senior Scientist, where they focused on understanding the drivers of early primary melanoma tumor progression. Karen also conducted research on the epigenome and intracellular signaling pathways associated with high-risk melanoma phenotypes.

Before joining Mount Sinai, Karen Mendelson worked at Weill Cornell Medical College for ten years. During their time there, they served as a Postdoctoral Associate and a Graduate Student. Their research during this period included studying sphingolipid signaling and metabolism using a zebrafish model of embryonic development. Karen also examined the role of S1P receptors and sphingosine kinase 2 in cardiovascular development.

Earlier in their career, Karen Mendelson worked as a Research Technician at Brigham and Women's Hospital. Their work focused on understanding heart valve development and pathology, as well as tissue engineering for potential valvular disease therapies.

Overall, Karen Mendelson has a diverse range of research experience, with a particular focus on cancer and cardiovascular biology. Karen has published numerous papers and secured research funding for their projects.

Karen Mendelson earned a PhD in Biomedical Research from the Joan & Sanford I. Weill Medical College of Cornell University, where they studied from 2006 to 2010. Prior to that, they completed their undergraduate studies at Princeton University from 1999 to 2003, earning an A.B. degree in Ecology and Evolutionary Biology. Karen also attended the Massachusetts Academy of Math and Science from 1997 to 1999, where they completed their high school education.